Kristin Ozelli oversees day-to-day operations, manages the editorial team and steers the production of articles, newsletters and multimedia content. She joined the Simons Foundation in 2017 as features editor of Spectrum. Previously, she was editorial director, online, and a senior editor at Scientific American, and a senior editor at Scientific American MIND. She has also written a book about Jupiter’s moons and volunteered at the Natural History Museum in London, assisting the curator of fossil cephalopods.
Kristin Ozelli
Executive editor
The Transmitter
From this contributor
Spotted around the web: INSAR; cerebellar gene expression; pangenome
Beyond the bench: Mastering meaningful movement with Karen Chenausky
Spotted around the web: Interpersonal synchrony, single-nucleotide polymorphisms, CRISPR at 10
Education
- M.A. in journalism, New York University
- B.S. in English, Massachusetts Institute of Technology
- B.S. in mathematics, Massachusetts Institute of Technology
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.